---
title: "China approves Huahui Health's Libevitug injection for treating hepatitis D; first of its kind; NMPA grants conditional approval."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273813786.md"
description: "On January 27, 2026, Huahui Health revealed that the China National Medical Products Administration (NMPA) has provided conditional approval for its Libevitug injection to address chronic hepatitis D virus infection in adults, with or without compensated cirrhosis."
datetime: "2026-01-27T08:21:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273813786.md)
  - [en](https://longbridge.com/en/news/273813786.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273813786.md)
---

# China approves Huahui Health's Libevitug injection for treating hepatitis D; first of its kind; NMPA grants conditional approval.

On January 27, 2026, Huahui Health revealed that the China National Medical Products Administration (NMPA) has provided conditional approval for its Libevitug injection to address chronic hepatitis D virus infection in adults, with or without compensated cirrhosis.

### Related Stocks

- [01515.HK](https://longbridge.com/en/quote/01515.HK.md)

## Related News & Research

- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)
- [12:36 ETDiagnostics Direct LLC Wins Innovation Award from Johns Hopkins](https://longbridge.com/en/news/286945918.md)
- [Lipocine Showcases Phase 3 Data for Postpartum Depression](https://longbridge.com/en/news/286923466.md)